Prohibition on Sale of PHI. Business Associate is prohibited from receiving any remuneration, directly or indirectly, in exchange for any PHI.
Prohibition on Sale of PHI. Business Associate shall not directly or indirectly receive remuneration in exchange for any PHI in violation of HIPAA. Business Associate shall not obtain an authorization for the sale of PHI except as expressly permitted in writing from the Xxxxxx Health Chief Privacy and Information Security Officer, and in accordance with the authorization requirements at 45 C.F.R. § 164.508 and Cal. Civ. Code 56.11.
Prohibition on Sale of PHI. Business Associate agrees to comply with the prohibition of sale of PHI without authorization unless an exception under 45 C.F.R. § 164.508 applies.
Prohibition on Sale of PHI. Business Associate must not sell PHI or receive any direct or indirect remuneration, compensation, or other consideration in exchange for PHI. Business Associate must not transmit to any Individual any communication about a product or service that encourages the recipient of the communication to purchase that product or service unless permitted to do so by HITECH Section 13405 and any implementing regulations.
Prohibition on Sale of PHI. Except as expressly permitted by HIPAA and state law, the Company shall refrain from receiving any remuneration in exchange for an individual’s PHI unless that exchange is pursuant to a valid authorization that meets the requirements of 45 CFR 164.508.
Prohibition on Sale of PHI. Except as otherwise expressly permitted by the HIPAA Rules, the Subcontractor shall not directly or indirectly receive remuneration, including financial or nonfinancial remuneration, in exchange for an Individual’s PHI unless the Covered Entity, Business Associate or the Subcontractor obtains a valid authorization that meets the requirements of 45 CFR § 164.508 and states that the disclosure will result in remuneration to the Covered Entity, Business Associate, or the Subcontractor.
Prohibition on Sale of PHI. Business Associate shall not directly or indirectly receive remuneration in exchange for any PHI of an individual unless the Covered Entity obtains from the individual a valid authorization that includes a specification of whether the PHI can be exchanged for remuneration by the entity receiving PHI of that individual.
Prohibition on Sale of PHI. Business Associate shall not sell PHI or receive any remuneration, direct or indirect, in exchange for PHI, except as expressly permitted by the Covered Entity.
Prohibition on Sale of PHI. CONTRACTOR is prohibited from receiving any remuneration, directly or indirectly, in exchange for any PHI, unless so allowed by the terms of the Contract. If the Contract so allows, CONTRACTOR shall not, directly or indirectly, receive any remuneration in exchange for PHI, unless KDHE first obtains a valid authorization from the Individual that includes, but is not limited to, a specification of whether the PHI can be further exchanged for remuneration by the entity receiving the PHI of the Individual. This prohibition does not apply if the purpose of the exchange is for: (i) public health activities; (ii) research; (iii) treatment of the Individual; (iv) health care operations; (v) remuneration that is provided by KDHE to CONTRACTOR for activities involving the exchange of PHI that CONTRACTOR undertakes on behalf of and at the specific request of KDHE pursuant to the Contract; (vi) to provide an Individual with a copy of the Individual’s PHI pursuant to 45 CFR § 164.524; or (vii) as otherwise determined by the Secretary in regulations to be similarly necessary and appropriate as the above cited exceptions.
Prohibition on Sale of PHI. Business Associate shall not directly or indirectly receive remuneration in exchange for a disclosure of PHI in violation of 45 C.F.R. § 164.502(a)(5)(ii), unless Covered Entity has provided Business Associate with a valid authorization from the Individual in accordance with 45 C.F.R. § 164.508(a)(4).
